Melanoma Therapeutics Market Size, Share, Leading Players and Analysis up to 2026
SEP 07,2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Melanoma Therapeutics Market.
The Melanoma Therapeutics Market is expected to grow from USD 4.8 billion in 2020 to USD 9.1 billion by 2026 at a CAGR of over 11.3% during the forecast period.
Skin cancer generally is of three types– squamous cell carcinoma, basal cell carcinoma, and melanoma. Melanoma is a type of skin cancer that forms from pigment-containing cells in the skin. It is more common in locations with a sunny climate and is the most serious of all types of skin cancers. UV radiations are the prime cause of melanoma.
Market Dynamics
The growing incidence of melanoma skin cancers is one of the key factors driving product consumption.
Also, growing awareness, the high adoption rate of these therapeutics among patients, technological developments further boost the market expansion. Moreover, favourable government initiatives for curbing skin cancers result in increasing healthcare expenditure, thus offering ample opportunities to the industry players. However, economic crisis, lack of product awareness in developing countries, and regulatory issues hinder the global melanoma therapeutics market growth.
Segment Analysis
Therapy Trends
Based on therapy, the global melanoma therapeutics market has been categorized into chemotherapy, immunotherapy, targeted therapy, and radiation therapy.
- Among these, the chemotherapy segment held a substantial market share in 2020.
- This can be ascribed to its high adoption rate in the past few years owing to the growing incidence of cancer, especially skin cancers.
- Chemotherapy includes a wide range of therapeutics that involve protein-related synthetically derived products.
Regional Trends
By region, the North America market witnessed the highest market share in 2020 and is projected to register a robust CAGR during the review period.
- This is majorly attributed to increasing incidence of melanoma and other skin cancers in the region.
- In 2013, as per CDC, over 71,943 people were affected by melanoma.
- According to the American Cancer Society, this number is projected to go up to 87,100 cases in 2017.
- These statistics highlight the need for drugs that help in the management of melanoma over the following years.
Key Players:
- AstraZeneca (UK),
- Amgen, Inc. (The U.S),
- F. Hoffman-La Roche Ltd. (Switzerland),
- Bristol-Myers Squibb Company (The U.S),
- Novartis AG (Switzerland),
- Merck & Co., Inc. (The U.S),
- Daiichi Sankyo Company Limited (Japan), and
- AB Sciences (France).
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
The Melanoma Therapeutics Market analysis report discusses the following heads in great detail:
- Market structure: Overview, industry life cycle analysis, supply chain analysis
- COVID-19 Impact Assessment
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Market trend and forecast analysis
- Market segment trend and forecast
- Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
- Attractive market segments and associated growth opportunities
- Emerging trends
- Strategic growth opportunities for the existing and new players
- Key success factors
Customization of the Report:
This report can be customized to meet the client’s requirements. In order to provide more accurate market forecast, all the reports are updated before delivery.
You can mail our sales team at (sales@stratviewresearch.com) and get in touch with us on +1-313-307-4176 to share your research requirements.
About Us: Stratview Research is a trusted global market intelligence and strategic consulting firm providing inclusive range of services to multiple clients across a wide array of industries. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.